$6.47
0.00% yesterday
Nasdaq, Dec 24, 03:30 pm CET
ISIN
AGP8696W1045
Symbol
SVA

Sinovac Biotech Ltd. Stock price

$6.47
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+0.00 0.00% 3Y
+0.00 0.00% 5Y
+0.76 13.31% 10Y
+2.12 48.74% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.00 0.00%
ISIN
AGP8696W1045
Symbol
SVA
Industry

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$10.6b
Shares outstanding
99.6m
Valuation (TTM | estimate)
P/E
negative | -
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
63.8%
Return on Equity
-1.2%
ROCE
-3.0%
ROIC
-45.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$429.2m | -
EBITDA
$-231.9m | -
EBIT
$-362.0m | -
Net Income
$-130.7m | -
Free Cash Flow
$-404.7m
Growth (TTM | estimate)
Revenue
2.2% | -
EBITDA
82.8% | -
EBIT
76.0% | -
Net Income
63.7% | -
Free Cash Flow
-84.0%
Margin (TTM | estimate)
Gross
92.1%
EBITDA
-54.0% | -
EBIT
-84.3%
Net
-30.5% | -
Free Cash Flow
-94.3%
More
EPS
$-1.3
FCF per Share
$-4.1
Short interest
0.3%
Employees
-
Rev per Employee
-
Show more

Is Sinovac Biotech Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Financial data from Sinovac Biotech Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
429 429
2% 2%
100%
- Direct Costs 34 34
95% 95%
8%
395 395
300% 300%
92%
- Selling and Administrative Expenses 443 443
51% 51%
103%
- Research and Development Expense 337 337
17% 17%
79%
-232 -232
83% 83%
-54%
- Depreciation and Amortization 130 130
20% 20%
30%
EBIT (Operating Income) EBIT -362 -362
76% 76%
-84%
Net Profit -131 -131
64% 64%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Sinovac Biotech Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sinovac Biotech Ltd. Stock News

Neutral
Business Wire
8 days ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Mr. Andrew Y. Yan and Mr. Yin Weidong (collectively, the Board), will comprise the ...
Neutral
Business Wire
about one month ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting determination letter (the “Staff Determination”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, unless the ...
Neutral
PRNewsWire
about one month ago
BOSTON , Nov. 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent Sinovac shareholders expressing overwhelming support for the immediate payment of a $19.00 dividend previously declared by the board.
More Sinovac Biotech Ltd. News

Company Profile

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Head office Antigua and Barbuda
CEO Wei Yin
Founded 1993
Website www.sinovac.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today